Jan Malý
Universidade Federal de Minas Gerais
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jan Malý.
Journal of Hypertension | 2009
Marcela Bürgelová; Zdenka Vaňourková; Monika Thumová; Pavel Dvořák; Martin Opočenský; Herbert J. Kramer; Michal Želízko; Jan Malý; Michael Bader; Luděk Červenka
Objective Recent studies have shown that the heptapeptide angiotensin-(1-7) [Ang-(1-7)] exerts important vasoactive actions and can act as an endogenous physiological antagonist of angiotensin II (Ang II) within the renin–angiotensin system (RAS). The present study was performed to evaluate the effects, first, of chronic increases of Ang-(1-7) levels, second, of [7-D-Ala], an Ang-(1-7) receptor antagonist, and, third, of an angiotensin-converting enzyme 2 (ACE2) inhibitor on the course of hypertension and of renal function of the nonclipped kidney in two-kidney, one-clip (2K1C) Goldblatt hypertensive rats. Methods Blood pressure (BP) was monitored by radiotelemetry. Elevation of the effect of circulating Ang-(1-7) levels was achieved either by chronic subcutaneous infusion of Ang-(1-7) through osmotic minipumps or by employing transgenic rats that express an Ang-(1-7)-producing fusion protein [Ang-(1-7)TGR+/+] (and its control Ang-(1-7)TGR−/−). [7-D-Ala] was also infused subcutaneously and the ACE2 inhibitor was administrated in drinking water. On day 25 after clipping, rats were anesthetized and renal function was evaluated. Results Chronic infusion of Ang-(1-7) did not modify the course of 2K1C hypertension and did not alter renal function as compared with saline vehicle-infused 2K1C rats. Chronic infusion of [7-D-Ala] or treatment with the ACE2 inhibitor worsened the course of hypertension and elicited decreases in renal hemodynamics. [Ang-(1-7)TGR+/+] and [Ang-(1-7)TGR−/−] rats exhibited a similar course of hypertension. Conclusion The present data support the notion that Ang-(1-7) serves as an important endogenous vasodilator and natriuretic agent and its deficiency might contribute to the acceleration of 2K1C Goldblatt hypertension.
Journal of Hypertension | 2008
Ludek Cervenka; Vanecková I; Zuzana Husková; Vanourková Z; M. Erbanová; Monika Thumová; Petra Škaroupková; Martin Opočenský; Jan Malý; Věra Čertíková Chábová; Tesar; Marcela Bürgelová; Viklický O; Teplan; Zelízko M; Herbert J. Kramer; Navar Lg
Objective The present study was performed to examine in two-kidney, one-clip (2K1C) Goldblatt hypertensive mice: first, the relative contribution of angiotensin II receptor subtypes 1A (AT1A) and 1B (AT1B); second, the role of angiotensin II type 2 (AT2) receptors in the development of hypertension in wild-type (AT1A+/+) and AT1A receptor knockout (AT1A−/−) mice; and third, the role of increased nitric oxide synthase activity in counteracting the hypertensinogenic action of angiotensin II in this model. Methods AT1A+/+ and AT1A−/− mice underwent clipping of one renal artery and were infused with either saline vehicle or selective AT2 receptor agonist CGP-42112A (CGP). Blood pressure was monitored by radiotelemetry. Blood pressure responses to the nitric oxide synthase inhibitor nitro-L-arginine-methyl-ester were evaluated. Results AT1A+/+ mice responded to clipping by a rise in blood pressure that was not modified by CGP infusion. Clip placement caused a slight increase in blood pressure in AT1A−/− mice that remained significantly lower than in AT1A+/+ mice. Acute nitric oxide synthase inhibition caused greater increase in blood pressure in 2K1C/AT1A+/+ than in AT1A+/+ mice. Conclusion The present data support the critical role of AT1A receptors in the development of 2K1C hypertension, whereas AT1B receptors play only a minor role in blood pressure regulation in this model of angiotensin II-dependent hypertension. Activation of AT2 receptors does not play an antagonistic role in the AT1 receptor-mediated hypertensinogenic actions of angiotensin II in this model. Finally, enhanced nitric oxide synthase activity plays a protective role by counteracting the vasoconstrictor influences of angiotensin II in 2K1C hypertensive mice.
Kidney & Blood Pressure Research | 2002
Marcela Bürgelová; Herbert J. Kramer; Vladimír Teplan; Gabriela Veličková; Stefan Vitko; Jiří Heller; Jan Malý; Luděk Červenka
In the present study we investigated the possible role of angiotensin-(1–7) [Ang-(1–7)] in modulating renal functional responses to intrarenal (i.e.) infusion of angiotensin II (ANG II) in normotensive anesthetized rats. ANG II (6 ng/min, n = 14) decreased glomerular filtration rate (GFR), renal plasma flow (RPF), absolute and fractional sodium excretion by –24 ± 5, –25 ± 6, –44 ± 6 and –28 ± 7%, respectively (p < 0.05). i.r. infusion of Ang-(1–7) (50 ng/min, n = 13) did not significantly alter GFR (+6 ± 4%) but reduced RPF by –19 ± 7% (p < 0.05). Ang-(1–7) increased absolute and fractional sodium excretion by +36 ± 6 and +37 ± 8%, respectively (p < 0.05). Infusion of Ang-(1–7) did not prevent the decreases in GFR and RPF but completely blunted the decreases in absolute (–2 ± 2%) and fractional sodium excretion (–4 ± 4%) induced by ANG II (n = 11). Blockade of the Ang-(1–7) receptor by [7-D-Ala]-Ang-(1–7) (5 µg/min, n = 11) significantly decreased GFR, RPF, absolute and fractional sodium excretion by –28 ± 7, –20 ± 5, –32 ± 7 and –24 ± 4%, respectively (p < 0.05), suggesting that the action of endogenous ANG II is unopposed by compensatory effect of endogenous Ang-(1–7). i.r. infusion of Ang-(1–7) (n = 10) did not alter the effect of Ang-(1–7) receptor blockade on RPF (–21 ± 6%) but blunted its effects on GFR (+4 ± 3%) and absolute (+7 ± 5%) and fractional (+6 ± 4%) urinary sodium excretion probably by displacing the receptor blocker. While exogenous ANG II during blockade of the Ang-(1–7) receptor and the AT2 receptor (by PD 123319; 1 µg/min i.r., n = 9) resulted in the same decreases in absolute and fractional sodium excretion (–39 ± 8 and –38 ± 6%, respectively, p < 0.05) as did ANG II in the absence of Ang-(1–7) receptor blockade. These results suggest that in normotensive rats high i.r. Ang-(1–7) concentration attenuates the tubular, i.e. sodium reabsorptive effect, but not the vascular effect of exogenous i.r. ANG II. Results obtained during blockade of Ang-(1–7) and of AT2 receptors imply that AT2 receptors play a role in tubular sodium reabsorption in the presence of high ANG II concentration
Kidney & Blood Pressure Research | 2010
Dan Rakušan; Marcela Bürgelová; Ivana Vaněčková; Zdeňka Vaňourková; Zuzana Husková; Petra Škaroupková; Iveta Mrázová; Martin Opočenský; Herbert J. Kramer; Ivan Netuka; Jan Malý; Natalia Alenina; Michael Bader; Robson A.S. Santos; Luděk Červenka
Aims: The present study was performed to evaluate the effects of target disruption of the G-protein-coupled receptor Mas for angiotensin 1–7 [Ang(1–7)] in knockout mice on the course of two-kidney, one-clip (2K1C) Goldblatt hypertension. Methods: Knockout and wild-type mice underwent clipping of one renal artery. Blood pressure (BP) was monitored by radiotelemetry. The mice were either untreated or chronically treated with the superoxide (O2–) scavenger tempol (400 mg/l) or the inhibitor of NADPH oxidase apocynin (1 g/l) administered in drinking water. Results: Knockout mice responded to clipping by accelerated increases in BP and the final BP was significantly higher than that in wild-type mice. Chronic treatment with tempol or apocynin elicited similar antihypertensive effects in 2K1C/knockout as in 2K1C/wild-type mice. Acute nitric oxide synthase inhibition caused greater BP increases in 2K1C/wild-type than in 2K1C/knockout mice. Conclusion: Our present findings support the notion that the angiotensin-converting enzyme 2-Ang(1–7)-Mas axis serves as an important endogenous physiological counterbalancing mechanism that partially attenuates the hypertensinogenic actions of the activated renin-angiotensin system. The impairment in this axis may contribute to the deterioration of the course of 2K1C Goldblatt hypertension.
Kidney & Blood Pressure Research | 2006
Zuzana Husková; Herbert J. Kramer; Monika Thumová; Zdenka Vaňourková; Marcela Bürgelová; Vladimír Teplan; Jan Malý; Luděk Červenka
Background: Previous studies have implicated that normotensive rats with normal renal renin activity respond to anesthesia and surgery with greater increases in plasma and kidney angiotensin II (ANG II) concentrations than ANG II-dependent hypertensive rats with intrarenal renin depletion. In the present study, we therefore compared plasma and kidney ANG II levels in anesthetized and conscious normotensive and ANG II-dependent hypertensive rats. Methods: Salt-replete Hannover-Sprague-Dawley rats (HanSD) served as controls. As models of ANG II-dependent hypertension we used: 1st, transgenic rats harboring the Ren-2 renin gene (TGR); 2nd, two-kidney, one-clip (2K1C) Goldblatt hypertensive rats, and, 3rd, ANG II-infused hypertensive rats. As additional model with enhanced renin-angiotensin system (RAS) activity, salt-depleted HanSD and TGR were employed. Results: In anesthetized salt-repleted HanSD, plasma and kidney ANG II levels were higher than in salt-repleted TGR, ANG II-infused and 2K1C rats. Salt depletion caused marked increases in ANG II levels in HanSD but did not alter them in TGR. In contrast, in conscious animals immediately after decapitation plasma and kidney ANG II levels were similar in salt-repleted and salt-depleted TGR, in ANG II-infused rats, in the clipped kidney of 2K1C rats and in salt-depleted HanSD and in all these groups they were significantly higher than in salt-repleted HanSD. Conclusions: These findings indicate that anesthesia increases plasma and kidney ANG II levels in HanSD to a greater degree than in ANG II-dependent models of hypertension. Therefore, the results from studies employing anesthetized animals must be interpreted with caution.
Kidney & Blood Pressure Research | 2004
Pavel Dvořák; Herbert J. Kramer; Angela Bäcker; Jan Malý; Libor Kopkan; Ivana Vaněčková; Zdena Vernerová; Martin Opočenský; Vladimír Tesař; Michael Bader; Detlev Ganten; Jan Janda; Luděk Červenka
Background/Aims: A growing body of evidence suggests that the interplay between the endothelin (ET) and the renin-angiotensin systems (RAS) plays an important role in the development of the malignant phase of hypertension. The present study was performed to evaluate the role of an interaction between ET and RAS in the development of hypertension and hypertension-associated end-organ damage in homozygous male transgenic rats harboring the mouse Ren-2 renin gene (TGRs) under conditions of normal-salt (NS, 0.45% NaCl) and high-salt (HS, 2% NaCl) intake. Methods: Twenty-eight-day-old homozygous male TGRs and age-matched transgene-negative male normotensive Hannover Sprague-Dawley (HanSD) rats were randomly assigned to groups with NS or HS intake. Nonselective ETA/B receptor blockade was achieved with bosentan (100 mg/kg/day). Systolic blood pressure (BP) was measured in conscious animals by tail plethysmography. Rats were placed into metabolic cages to determine proteinuria and clearance of endogenous creatinine. At the end of the experiment the final arterial BP was measured directly in anesthetized rats. Kidneys were taken for morphological examination. Results: All male HanSD fed either the NS or HS diet exhibited a 100% survival rate until 180 days of age (end of experiment). The survival rate in untreated homozygous male TGRs fed the NS diet was 41%, which was markedly improved by treatment with bosentan to 88%. The HS diet reduced the survival rate in homozygous male TGRs to 10%. The survival rate in homozygous male TGRs on the HS diet was significantly improved by bosentan to 69%. Treatment with bosentan did not influence either the course of hypertension or the final levels of BP in any of the experimental groups of HanSD rats or TGRs. Although the ET-1 content in the renal cortex did not differ between HanSD rats and TGRs, ET-1 in the left heart ventricle of TGRs fed the HS diet was significantly higher compared with all other groups. Administration of bosentan to homozygous male TGRs fed either the NS or HS diet markedly reduced proteinuria, glomerulosclerosis and attenuated the development of cardiac hypertrophy compared with untreated TGR. Conclusions: Our data show that nonselective ETA/B receptor blockade markedly improves the survival rate and ameliorates end-organ damage in homozygous male TGRs without significantly lowering BP.
Clinical and Experimental Pharmacology and Physiology | 2010
Petr Kujal; Věra Čertíková Chábová; Zdenka Vernerová; Agnieszka Walkowska; Elzbieta Kompanowska-Jezierska; Janusz Sadowski; Zdeňka Vaňourková; Zuzana Husková; Martin Opočenský; Petra Škaroupková; Stanislava Schejbalová; Herbert J. Kramer; Dan Rakušan; Jan Malý; Ivan Netuka; Ivana Vaněčková; Libor Kopkan; Luděk Červenka
1. Hypertension plays a critical role in the progression of chronic kidney disease (CKD) to end‐stage renal disease (ESRD), but it has also been postulated that antihypertensive drugs that block the renin‐angiotensin system (RAS) show class‐specific renoprotective actions beyond their blood pressure (BP)‐lowering effects.
Vascular Pharmacology | 2009
Libor Kopkan; Zuzana Husková; Zdeňka Vaňourková; Monika Thumová; Petra Škaroupková; Jan Malý; Herbert J. Kramer; Pavel Dvořák; Luděk Červenka
Results of our previous studies have suggested that enhanced generation of superoxide (O2(-)) may contribute to the pathophysiology of hypertension in Ren-2 transgenic rats (TGR). The present study was performed to evaluate in TGR the effects of chronic treatment with the O2(-) scavenger tempol and the antioxidant apocynin on the development of hypertension. Systolic blood pressure (SBP) was monitored from 30 to 99 days of age in TGR and in normotensive Hannover Sprague-Dawley (HanSD) rats. At the end of the experiment, urinary protein and 8-isoprostane excretion were determined and angiotensin II (ANG II) and malondialdehyde (MDA) levels were measured in kidney and cardiac tissues. Cardiac hypertrophy was assessed as the ratio of left heart ventricle weight to tibia length (LVW/TL). Although tempol and apocynin treatment in TGR significantly decreased 8-isoprostane excretion and MAD tissue concentrations as compared with untreated TGR, it did not alter the course of SBP, LVW/TL ratio, proteinuria or ANG II levels that were enhanced as compared with HanSD rats. Our data suggest that the development of hypertension in TGR is clearly ANG II-dependent but the contribution of oxidative stress to the development of hypertension in this model appears to be negligible.
Wiener Klinische Wochenschrift | 2008
Vladimír Teplan; Otto Schück; Jaroslav Racek; Olga Marečková; Milena Stollova; Vladimir Hanzal; Jan Malý
ZusammenfassungHINTERGRUND: Die Plasmaspiegel des endogenen Stickoxid-Hemmers asymmetrisches Dimethylarginin (ADMA) sind bei chronischem Nierenversagen erhöht und könnten zu den vaskulären Komplikationen beitragen. In dieser Studie wurde die Hypothese überprüft, ob diese erhöhten ADMA-Spiegel bei übergewichtigen CNV-Patienten durch eine Langzeittherapie mit einer Ketosäuren-supplementierten niedrigprotein-Diät (KA) vermindert werden könnten. PATIENTEN UND METHODEN: Insgesamt 111 CNV-Patienten (54 M/57 F) mit Adipositas (BMI ≥ 30 kg/m2), Alter 22–76 Jahre und einer Inulin-Clearance von 22–40 ml/min/1,73 m2 wurden in eine randomisiert-kontrollierte doppel-blinden Untersuchung einschlossen. Die Patienten erhielten über 336 Monate eine Niedrig-Protein-Diät (LPD) von 0,6 Protein/kg KG/Tag und 120–125/kJ/kg KG/Tag. In 66 Patienten, Gruppe I, wurde diese LPD mit KA (100 mg/kg KG/Tag) supplementiert, 65 Patienten (Gruppe II) erhielten Placebo. ERGEBNISSE: Während der Studienperiode nahm die glomeruläre Filtrationsrate leicht ab (Cin von 32,4 ± 12,6 auf 29,8 ± 8,6 ml/min/1,73m2 und 33,2 ± 12,6 auf 23,2 ± 98,4 ml/min/1,73 m2 in den Gruppen I und II; dies war ausgeprägter in Grupppe II (p < 0,01)). Der BMI verminderte sich in Gruppe I von 32.0 ± 3.3 auf 26.1 ± 4.0 kg/m2 (p < 0,01), dies war auf einen Rückgang des viszeralen Fettes gemessen mit MRI zurückzuführen (p < 0,01). Die Änderung des BMI war in Gruppe II nicht signifikant. In Gruppe I fand sich ein Rückgang des Plasmaspiegel von ADMA von 2,5 ± 0,5 auf 1,3 ± 0,4 µmol/l (p < 0,01), dieser blieb in Gruppe II unverändert. In Gruppe I fand sich auch ein Rückgang der Plasma-Konzentration von Pentosidin (von 480 ± 170 auf 320 ± 120 µg/L, p < 0,01) und der Proteinurie (von 3,8 ± 2,24 auf 1,6 ± 1,0 g / 24 h, p < 0,02). Plasma Adiponectin (ADPN) stieg in Gruppe I an (p < 0,01). Ausgeprägter in Gruppe I fand sich ein leichter Abfall von Gesamtcholesterin und LDL-Cholesterin (p < 0,02). In Gruppe I fielen die Plasma-Triglyzeride (von 3,9 ± 1,6 auf 2,2 ± 0,6 mmol/l, p < 0,01), das glykierte Hämoglobin (HbAc1) von 7,2 ± 1,4 auf 4,2 ± 0,8% (p < 0,02). ZUSAMMENFASSUNG: Bei übergewichtigen Patienten mit CNV führt eine Langzeit-Gabe von Ketosäuren zusammen mit einer LPD in Vergleich zu Placebo zu einer Verminderung des viszeralen Körperfettes und zu einer Verzögerung des Nierenfunktionsverlustes. Ein gleichzeitiger Rückgang des Plasmaspiegels von ADMA, aber auch von Pentosidin könnten zusammen mit einem Rückgang der Proteinurie zu einer Vermindung der Progression des Nierenversagens beitragen.SummaryBACKGROUND: Levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) are elevated in chronic kidney disease (CKD) and may contribute to vascular complications. In this study we tested the hypothesis that elevated ADMA can be reduced in obese CKD patients by long-term administration of a low-protein diet supplemented with keto-amino acids. PATIENTS AND METHODS: In a long-term prospective double-blind placebo-controlled randomized trial, we evaluated for a period of 36 months a total of 111 CKD patients (54 men, 57 women) aged 22–76 years with obesity (BMI ≥ 30 kg/m2) and an inulin clearance rate (Cin) of 22–40 ml/min/1.73 m2. All patients were on a low-protein diet containing 0.6 g protein/kg BW per day and 120–125 kJ/kg BW per day. The diet was randomly supplemented with keto-amino acids at a dosage of 100 mg/kg BW per day (66 patients, Group I); 65 patients received placebo (Group II). RESULTS: During the study period, the glomerular filtration rate decreased slightly in Group I (Cin from 32.4 ± 12.6 to 29.8 ± 8.6 ml/min/1.73 m2) and more markedly in Group II (from 33.2 ± 12.6 to 23.2 ± 98.4 ml/min/1.73m2, P < 0.01). BMI decreased significantly in Group I (from 32.0 ± 3.3 to 26.1 ± 4.0 kg/m2, P < 0.01) and was linked to reduced volume of visceral fat measured by MRI (P < 0.01). Reduction of BMI in Group II was not significant. In Group I, there was a significant decrease in the plasma level of ADMA (from 2.5 ± 0.5 to 1.3 ± 0.4 µmol/l, P < 0.01), but ADMA remained unchanged in Group II. A further remarkable finding in Group I was reduction in the plasma concentration of pentosidine (from 480 ± 170 to 320 ± 120 µg/l, P < 0.01) and decrease of proteinuria (from 3.8 ± 2.24 to 1.6 ± 1.0 g/24 h, P < 0.02). Plasma adiponectin rose in Group I (P < 0.01). Analysis of the lipid spectrum revealed a mild but significant decrease in total cholesterol and LPD-cholesterol (P < 0.02), more pronounced in Group I. There was also a decrease in plasma triglycerides in Group I (from 3.9 ± 1.6 down to 2.2 ± 0.6 mmol/l, P < 0.01) and a decrease in glycated hemoglobin (from 7.2 ± 1.4% to 4.2 ± 0.8%, P < 0.02). CONCLUSION: Compared with the placebo group, long term co-administration of a low-protein diet and keto-amino acids in CKD patients with obesity led to decreases of ADMA, visceral body fat and proteinuria. Concomitant decreases of glycated hemoglobin, LDL-cholesterol and pentosidine may also contribute to the delay in progression of renal failure.
Kidney & Blood Pressure Research | 2007
Zuzana Husková; Herbert J. Kramer; Zdenka Vaňourková; Monika Thumová; Jan Malý; Martin Opočenský; Petra Škaroupková; Alexander Kolský; Zdena Vernerová; Luděk Červenka
Background: In the present study we evaluated plasma and kidney angiotensin II (ANG II) levels in female and male Ren-2 transgenic rats (TGR) in comparison to age-matched female and male normotensive Hannover Sprague-Dawley rats. Methods: The rats were maintained on a normal sodium (NS) diet (0.6% NaCl) or fed a high sodium (HS) diet (2% NaCl) for 4 days or were sodium depleted by administration of 40 mg furosemide per liter drinking water overnight followed by 3 days of low sodium diet (0.01% NaCl) (LS + F). ANG II levels were determined by radioimmunoassay. Results: Female TGR at the age of 38 days were already hypertensive and had developed cardiac hypertrophy, whereas male TGR at this age still exhibited a normotensive phenotype. HS diet increased the blood pressure (BP) but did not alter the ANG II levels in TGR at any age. LS + F decreased the BP without significant change in ANG II concentrations in TGR. Female TGR responded to salt loading and salt depletion by more pronounced changes in BP than male TGR. Conclusions: Female TGR develop hypertension more rapidly and the salt-sensitive component of hypertension is more pronounced in female than in male TGR.